Emergent BioSolutions Inc.

12/16/2024 | Press release | Distributed by Public on 12/16/2024 07:00

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)